CM
JNCE

Crestline Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

Crestline Management’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13,212
Closed -$295K – 298
2018
Q1 		$295K Buy
+13,212
New +$295K 0.04% 204